Among the drugs targeting Gln transporters for DSMTs treatment, only the LAT1 inhibitor JPH203 has entered clinical trials
Methotrexate commonly causes nausea, vomiting, and abdominal discomfort, particularly in the days following administration
[DOI] [PMC free article] [PubMed] [Google Scholar] [16].Handy DE, Lubos E, Yang Y, Galbraith JD, Kelly N, Zhang YY, Leopold JA, Loscalzo J, Glutathione peroxidase-1 regulates mitochondrial function to modulate redox-dependent cellular responses
Nearly two-thirds say their shopping habits have changed since they began taking a GLP-1 medication for weight loss
Clinical trials get hopeful treatments to more people faster when what is available may not work for everyone
Tirzepatide should not be used in type 1 diabetes, diabetic ketoacidosis, or severe gastrointestinal disease including gastroparesis